MRI with magnetic nanoparticles monitors downstream anti-angiogenic effects of mTOR inhibition

Alexander R. Guimaraes, Robert Ross, Jose L. Figuereido, Peter Waterman, Ralph Weissleder

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Purpose: To study the effect of mammalian target of rapamycin (mTOR) inhibition on angiogenesis with magnetic resonance imaging (MRI) using magnetic iron oxide nanoparticles (MNP). Procedures: One million CAK-1 renal cell carcinoma cells were subcutaneously implanted into each of 20 nude mice. When tumors reached ∼750 μl, four daily treatment arms began and continued for 4 weeks: rapamycin (mTOR inhibitor) 10 mg/kg/day; sorafenib (VEGF inhibitor) high dose (80 mg/kg/day) and low dose (30 mg/kg/day); and saline control. Weekly MRI (4.7 T Bruker Pharmascan) was performed before and after IV MION-48, a prototype MNP similar to MNP in clinical trials. Vascular volume fraction (VVF) was quantified as ΔR2 (from multi-contrast T2 sequences) and normalized to assumed muscle VVF of 3%. Linear regression compared VVF to microvascular density (MVD) as determined by histology. Results: VVF correlated with MVD (R 2=0.95). VVF in all treatment arms differed fromcontrol (p<0.05) and declined weekly with treatment. VVF changes with rapamycin were similar to high-dose sorafenib. Conclusion: This study demonstrates noninvasive, in vivo anti-angiogenic monitoring using MRI of mTOR inhibition.

Original languageEnglish (US)
Pages (from-to)314-320
Number of pages7
JournalMolecular Imaging and Biology
Volume13
Issue number2
DOIs
StatePublished - Apr 1 2011

Keywords

  • Angiogenesis
  • MRI
  • Magnetic nanoparticle imaging
  • Magnetic resonance imaging
  • Renal cell cancer
  • Ultrasmall superparamagnetic iron oxide nanoparticle
  • mTOR

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'MRI with magnetic nanoparticles monitors downstream anti-angiogenic effects of mTOR inhibition'. Together they form a unique fingerprint.

Cite this